The Food and Drug Administration (FDA) has cleared TrueFusion, a new cardiovascular application from Siemens Healthineers that integrates ultrasound and angiography images to guide cardiac teams when administering treatment for structural heart disease.

The American College of Cardiology (ACC), partnering with nine other societies, released appropriate use criteria for imaging tests of valvular heart disease. The Sept. 1 document addresses evaluation and use of imaging in diagnosing and managing the condition.

The business of cardiology was at the forefront of discussion at the Society for Cardiovascular Angiography and Interventions (SCAI) Cath Lab Leadership Boot Camp in May. Speakers focused on the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), bundled payment models and value-based reimbursement. Here are a few of the lessons attendees took back to their practices.

Cardiology’s Shark Tank will be back for its fourth year when TCT convenes Oct. 29-Nov. 2, in Denver. Program Director Juan F. Granada, MD, shares insights from the conference’s innovation competition.

A man born with a congenital heart murmur developed systemic arterial hypertension as an adult. At age 50, he went to the hospital because of dyspnea. He also had a pulmonic valve ejection click and murmur of pulmonic stenosis. When at the hospital, his echocardiogram showed hypertrophy of both ventricles as well as an enlarged right atrium.

To date, clinicians have lacked a noninvasive technique for the assessment of coronary flow reserve, but a new study offers a promise of just such a technique.

For revascularized ST-segment elevation myocardial infarction (STEMI) patients, early post-infarction cardiac MRI parameters offer long-term predictive value that is superior to that offered by traditional outcome predictors, a large, long-term European study has found.